PDB Short entry for 3EOV
HEADER    ISOMERASE/IMMUNOSUPPRESSANT             29-SEP-08   3EOV              
TITLE     CRYSTAL STRUCTURE OF CYCLOPHILIN FROM LEISHMANIA DONOVANI LIGATED WITH
TITLE    2 CYCLOSPORIN A                                                        
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE;                       
COMPND   3 CHAIN: A, B;                                                         
COMPND   4 SYNONYM: PPIASE, ROTAMASE, CYCLOPHILIN;                              
COMPND   5 EC: 5.2.1.8;                                                         
COMPND   6 ENGINEERED: YES;                                                     
COMPND   7 MOL_ID: 2;                                                           
COMPND   8 MOLECULE: CYCLOSPORIN A;                                             
COMPND   9 CHAIN: C, D;                                                         
COMPND  10 SYNONYM: CICLOSPORIN, CICLOSPORINE;                                  
COMPND  11 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: LEISHMANIA DONOVANI;                            
SOURCE   3 ORGANISM_TAXID: 5661;                                                
SOURCE   4 GENE: CYP;                                                           
SOURCE   5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   6 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE   7 EXPRESSION_SYSTEM_STRAIN: M15;                                       
SOURCE   8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE   9 EXPRESSION_SYSTEM_PLASMID: PQE32;                                    
SOURCE  10 MOL_ID: 2;                                                           
SOURCE  11 SYNTHETIC: YES;                                                      
SOURCE  12 ORGANISM_SCIENTIFIC: TOLYPOCLADIUM INFLATUM;                         
SOURCE  13 ORGANISM_TAXID: 29910                                                
KEYWDS    ISOMERASE-IMMUNOSUPPRESSANT COMPLEX, CYCLOPHILIN-CYCLOSPORIN COMPLEX, 
KEYWDS   2 CYCLOSPORIN A, IMMUNOSUPPRESSANT, CYCLOPHILIN                        
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    V.VENUGOPAL,D.DASGUPTA,A.K.DATTA,R.BANERJEE                           
REVDAT   5   27-JUL-11 3EOV    1       ATOM   HEADER HETATM KEYWDS              
REVDAT   5 2                   1       REMARK REVDAT SEQRES                     
REVDAT   4   13-JUL-11 3EOV    1       VERSN                                    
REVDAT   3   15-JUN-11 3EOV    1       JRNL                                     
REVDAT   2   24-FEB-09 3EOV    1       VERSN                                    
REVDAT   1   11-NOV-08 3EOV    0                                                
JRNL        AUTH   V.VENUGOPAL,A.K.DATTA,D.BHATTACHARYYA,D.DASGUPTA,R.BANERJEE  
JRNL        TITL   STRUCTURE OF CYCLOPHILIN FROM LEISHMANIA DONOVANI BOUND TO   
JRNL        TITL 2 CYCLOSPORIN AT 2.6 A RESOLUTION: CORRELATION BETWEEN         
JRNL        TITL 3 STRUCTURE AND THERMODYNAMIC DATA.                            
JRNL        REF    ACTA CRYSTALLOGR.,SECT.D      V.  65  1187 2009              
JRNL        REFN                   ISSN 0907-4449                               
JRNL        PMID   19923714                                                     
JRNL        DOI    10.1107/S0907444909034234                                    
REMARK   1                                                                      
REMARK   1 REFERENCE 1                                                          
REMARK   1  AUTH   V.VENUGOPAL,B.SEN,A.K.DATTA,R.BANERJEE                       
REMARK   1  TITL   STRUCTURE OF CYCLOPHILIN FROM LEISHMANIA DONOVANI AT 1.97 A  
REMARK   1  TITL 2 RESOLUTION.                                                  
REMARK   1  REF    ACTA CRYSTALLOGR.,SECT.F      V.  63    60 2007              
REMARK   1  REFN                   ESSN 1744-3091                               
REMARK   1  PMID   17277440                                                     
REMARK   1  DOI    10.1107/S1744309106056351                                    
REMARK   1 REFERENCE 2                                                          
REMARK   1  AUTH   M.DUTTA,P.DELHI,K.M.SINHA,R.BANERJEE,A.K.DATTA               
REMARK   1  TITL   LACK OF ABUNDANCE OF CYTOPLASMIC CYCLOSPORIN A- BINDING      
REMARK   1  TITL 2 PROTEIN RENDERS FREE-LIVING LEISHMANIA DONOVANI RESISTANT TO 
REMARK   1  TITL 3 CYCLOSPORIN A.                                               
REMARK   1  REF    J.BIOL.CHEM.                  V. 276 19294 2001              
REMARK   1  REFN                   ISSN 0021-9258                               
REMARK   1  PMID   11278494                                                     
REMARK   1  DOI    10.1074/JBC.M009379200                                       
REMARK   2                                                                      
REMARK   2 RESOLUTION.    2.60 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CNS 1.2                                              
REMARK   3   AUTHORS     : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-              
REMARK   3               : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,              
REMARK   3               : READ,RICE,SIMONSON,WARREN                            
REMARK   3                                                                      
REMARK   3  REFINEMENT TARGET : NULL                                            
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 27.48                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   DATA CUTOFF HIGH         (ABS(F)) : 780102.190                     
REMARK   3   DATA CUTOFF LOW          (ABS(F)) : 0.0000                         
REMARK   3   COMPLETENESS (WORKING+TEST)   (%) : 95.1                           
REMARK   3   NUMBER OF REFLECTIONS             : 12040                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE            (WORKING SET) : 0.207                           
REMARK   3   FREE R VALUE                     : 0.251                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 5.200                           
REMARK   3   FREE R VALUE TEST SET COUNT      : 623                             
REMARK   3   ESTIMATED ERROR OF FREE R VALUE  : 0.010                           
REMARK   3                                                                      
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
REMARK   3   TOTAL NUMBER OF BINS USED           : 6                            
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 2.60                         
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 2.76                         
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 94.20                        
REMARK   3   REFLECTIONS IN BIN    (WORKING SET) : 1968                         
REMARK   3   BIN R VALUE           (WORKING SET) : 0.3150                       
REMARK   3   BIN FREE R VALUE                    : 0.2110                       
REMARK   3   BIN FREE R VALUE TEST SET SIZE  (%) : 0.10                         
REMARK   3   BIN FREE R VALUE TEST SET COUNT     : 2                            
REMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE : 0.149                        
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 2728                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 0                                       
REMARK   3   SOLVENT ATOMS            : 76                                      
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 52.40                          
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 49.60                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : 12.41000                                             
REMARK   3    B22 (A**2) : 2.40000                                              
REMARK   3    B33 (A**2) : -14.81000                                            
REMARK   3    B12 (A**2) : 0.00000                                              
REMARK   3    B13 (A**2) : 1.40000                                              
REMARK   3    B23 (A**2) : 0.00000                                              
REMARK   3                                                                      
REMARK   3  ESTIMATED COORDINATE ERROR.                                         
REMARK   3   ESD FROM LUZZATI PLOT        (A) : 0.34                            
REMARK   3   ESD FROM SIGMAA              (A) : 0.43                            
REMARK   3   LOW RESOLUTION CUTOFF        (A) : 5.00                            
REMARK   3                                                                      
REMARK   3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.                         
REMARK   3   ESD FROM C-V LUZZATI PLOT    (A) : 0.43                            
REMARK   3   ESD FROM C-V SIGMAA          (A) : 0.53                            
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.                                   
REMARK   3   BOND LENGTHS                 (A) : 0.008                           
REMARK   3   BOND ANGLES            (DEGREES) : 1.40                            
REMARK   3   DIHEDRAL ANGLES        (DEGREES) : 25.10                           
REMARK   3   IMPROPER ANGLES        (DEGREES) : 0.78                            
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL MODEL : RESTRAINED                                
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA                
REMARK   3   MAIN-CHAIN BOND              (A**2) : NULL  ; NULL                 
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : NULL  ; NULL                 
REMARK   3   SIDE-CHAIN BOND              (A**2) : NULL  ; NULL                 
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED : FLAT MODEL                                           
REMARK   3   KSOL        : 0.35                                                 
REMARK   3   BSOL        : 57.60                                                
REMARK   3                                                                      
REMARK   3  NCS MODEL : NULL                                                    
REMARK   3                                                                      
REMARK   3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT          
REMARK   3   GROUP  1  POSITIONAL            (A) : NULL  ; NULL                 
REMARK   3   GROUP  1  B-FACTOR           (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  PARAMETER FILE  1  : PROTEIN_REP.PARAM                              
REMARK   3  PARAMETER FILE  2  : WATER_REP.PARAM                                
REMARK   3  PARAMETER FILE  3  : CSA.PARAM                                      
REMARK   3  PARAMETER FILE  4  : NULL                                           
REMARK   3  TOPOLOGY FILE  1   : PROTEIN.TOP                                    
REMARK   3  TOPOLOGY FILE  2   : WATER.TOP                                      
REMARK   3  TOPOLOGY FILE  3   : CSA.TOP                                        
REMARK   3  TOPOLOGY FILE  4   : NULL                                           
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 3EOV COMPLIES WITH FORMAT V. 3.15, 01-DEC-08                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-NOV-08.                  
REMARK 100 THE RCSB ID CODE IS RCSB049590.                                      
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 01-JAN-08                          
REMARK 200  TEMPERATURE           (KELVIN) : 293.0                              
REMARK 200  PH                             : 8.50                               
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : N                                  
REMARK 200  RADIATION SOURCE               : ROTATING ANODE                     
REMARK 200  BEAMLINE                       : NULL                               
REMARK 200  X-RAY GENERATOR MODEL          : RIGAKU RU200                       
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.5418                             
REMARK 200  MONOCHROMATOR                  : MIRRORS                            
REMARK 200  OPTICS                         : OSMIC MAXFLUX CONFOCAL MULTILAY    
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : IMAGE PLATE                        
REMARK 200  DETECTOR MANUFACTURER          : MAR SCANNER 300 MM PLATE           
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO                              
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK                          
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 12040                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 2.600                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 30.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 2.000                              
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 95.3                               
REMARK 200  DATA REDUNDANCY                : 4.110                              
REMARK 200  R MERGE                    (I) : 0.05200                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 14.1000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 2.69                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 96.5                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 5.30                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.25100                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 2.600                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: AMORE                                                 
REMARK 200 STARTING MODEL: PDB ENTRY 2HAQ                                       
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 52.22                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.57                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.02M TRIS, 15% PEG3350, 0.1M NACL,      
REMARK 280  0.02% AZIDE, PH 8.5, 6% ETHYL ALCOHOL, CONCENTRATION: 10 MG/ML 1:   
REMARK 280  1 CYCLOPHILIN-CYCLOSPORIN COMPLEX, TEMPERATURE 292K, BATCH          
REMARK 280  METHOD, PH 8.50, SMALL TUBES                                        
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1                          
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,Y,-Z                                                 
REMARK 290       3555   X+1/2,Y+1/2,Z                                           
REMARK 290       4555   -X+1/2,Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000            
REMARK 290   SMTRY1   3  1.000000  0.000000  0.000000       34.90500            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       41.56250            
REMARK 290   SMTRY3   3  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   4 -1.000000  0.000000  0.000000       34.90500            
REMARK 290   SMTRY2   4  0.000000  1.000000  0.000000       41.56250            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1, 2                                                    
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 980 ANGSTROM**2                           
REMARK 350 SURFACE AREA OF THE COMPLEX: 7930 ANGSTROM**2                        
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.6 KCAL/MOL                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 2                                                       
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 980 ANGSTROM**2                           
REMARK 350 SURFACE AREA OF THE COMPLEX: 8020 ANGSTROM**2                        
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.6 KCAL/MOL                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 400                                                                      
REMARK 400 COMPOUND                                                             
REMARK 400 CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.                               
REMARK 400 HERE, CYCLOSPORIN A IS REPRESENTED BY THE SEQUENCE (SEQRES)          
REMARK 400                                                                      
REMARK 400  GROUP: 1                                                            
REMARK 400   NAME: CYCLOSPORIN A                                                
REMARK 400   CHAIN: C, D                                                        
REMARK 400   COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 11                
REMARK 400   DESCRIPTION: CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.                
REMARK 400                CYCLIZATION IS ACHIEVED BY LINKING THE N- AND         
REMARK 400                THE C- TERMINI.                                       
REMARK 465                                                                      
REMARK 465 MISSING RESIDUES                                                     
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
REMARK 465                                                                      
REMARK 465   M RES C SSSEQI                                                     
REMARK 465     HIS A    16                                                      
REMARK 465     HIS A    17                                                      
REMARK 465     HIS A    18                                                      
REMARK 465     HIS A    19                                                      
REMARK 465     HIS A    20                                                      
REMARK 465     HIS A    21                                                      
REMARK 465     HIS B    16                                                      
REMARK 465     HIS B    17                                                      
REMARK 465     HIS B    18                                                      
REMARK 465     HIS B    19                                                      
REMARK 465     HIS B    20                                                      
REMARK 465     HIS B    21                                                      
REMARK 470                                                                      
REMARK 470 MISSING ATOM                                                         
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;           
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;          
REMARK 470 I=INSERTION CODE):                                                   
REMARK 470   M RES CSSEQI  ATOMS                                                
REMARK 470     GLU A  22    CG   CD   OE1  OE2                                  
REMARK 470     GLN A  81    CG   CD   OE1  NE2                                  
REMARK 470     GLU B  22    CG   CD   OE1  OE2                                  
REMARK 470     GLN B  81    CG   CD   OE1  NE2                                  
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ASP A  36       81.17     53.34                                   
REMARK 500    SER A  37      -18.14     61.19                                   
REMARK 500    ALA A  52       76.10   -159.68                                   
REMARK 500    ASP A  73       -7.03     88.28                                   
REMARK 500    PHE A  83      -76.64   -150.11                                   
REMARK 500    ASN A  92      -21.69   -148.84                                   
REMARK 500    ASP A 156      145.85   -170.33                                   
REMARK 500    THR A 167      155.32    -46.19                                   
REMARK 500    SER A 171      170.77    -57.02                                   
REMARK 500    PRO B  23      178.16    -57.68                                   
REMARK 500    ASP B  36       88.70     63.90                                   
REMARK 500    SER B  37      -17.31     73.73                                   
REMARK 500    ALA B  52       78.34   -163.25                                   
REMARK 500    GLU B  66      -60.40    -29.60                                   
REMARK 500    ASP B  73       -2.23     74.66                                   
REMARK 500    ARG B  78      113.75   -163.84                                   
REMARK 500    PHE B  83      -68.67   -131.33                                   
REMARK 500    ASN B 124     -166.41   -161.13                                   
REMARK 500    THR B 167      156.07    -40.19                                   
REMARK 500    ASN B 170     -168.38   -127.12                                   
REMARK 500    SER B 171      156.49    -46.83                                   
REMARK 500    HIS B 172       -6.38     69.63                                   
REMARK 500    MVA C   4       73.73   -118.35                                   
REMARK 500    VAL C   9       98.72     72.85                                   
REMARK 500    MLE C  10     -152.29   -108.96                                   
REMARK 500    VAL D   9       99.63     76.43                                   
REMARK 500    MLE D  10     -145.39   -108.99                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF CYCLOSPORIN A          
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF CYCLOSPORIN A          
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1BCK   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH              
REMARK 900 CYCLOSPORIN C                                                        
REMARK 900 RELATED ID: 1C5F   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE CYCLOPHILIN-LIKE DOMAIN FROM                
REMARK 900 BRUGIA MALAYI COMPLEXED WITH CYCLOSPORIN A                           
REMARK 900 RELATED ID: 1CSA   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF E.COLI CYCLOPHILIN (F112W) COMPLEXED           
REMARK 900 WITH CYCLOSPORIN A                                                   
REMARK 900 RELATED ID: 1CWA   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH              
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 1CWB   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH              
REMARK 900 MODIFIED CYCLOSPORIN A AT POSITION 5                                 
REMARK 900 RELATED ID: 1CWC   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH              
REMARK 900 MODIFIED CYCLOSPORIN A AT POSITION 8                                 
REMARK 900 RELATED ID: 1CWF   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH              
REMARK 900 CYCLOSPORIN D                                                        
REMARK 900 RELATED ID: 1CWH   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH              
REMARK 900 CYCLOSPORIN A MODIFIED AT POSITION 7                                 
REMARK 900 RELATED ID: 1CWI   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH              
REMARK 900 MODIFIED CYCLOSPORIN D AT POSITION 7                                 
REMARK 900 RELATED ID: 1CWJ   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH              
REMARK 900 MODIFIED CYCLOSPORIN D AT POSITIONS 5 AND 7.                         
REMARK 900 RELATED ID: 1CWK   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH              
REMARK 900 MODIFIED CYCLOSPORIN D AT POSITIONS 5 AND 7.                         
REMARK 900 RELATED ID: 1CWL   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH              
REMARK 900 MODIFIED CYCLOSPORIN A AT POSITION 8                                 
REMARK 900 RELATED ID: 1CWM   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH              
REMARK 900 MODIFIED CYCLOSPORIN A AT POSITION 8                                 
REMARK 900 RELATED ID: 1CWO   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH              
REMARK 900 NODIFIED CYCLOSPORIN C AT POSITIONS 1, AND 9                         
REMARK 900 RELATED ID: 1CYA   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WIYH               
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 1CYB   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WITH               
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 1CYN   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN B COMPLEXED WITH              
REMARK 900 MODIFIED CYCLOSPORIN A                                               
REMARK 900 RELATED ID: 1IKF   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF CTCLOSPORIN-FAB COMPLEX                         
REMARK 900 RELATED ID: 1M63   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF CALCINEURIN-CYCLOPHILIN-CYCLOSPORIN             
REMARK 900 COMPLEX                                                              
REMARK 900 RELATED ID: 1MF8   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITH HUMAN          
REMARK 900 CYCLOPHILIN AND CYCLOSPORIN A                                        
REMARK 900 RELATED ID: 1MIK   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH              
REMARK 900 MODIFIED CYCLOSPORIN A AT POSITION 6                                 
REMARK 900 RELATED ID: 1QNG   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN               
REMARK 900 COMPLEXED WITH CYCLOSPORIN A                                         
REMARK 900 RELATED ID: 1QNH   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN               
REMARK 900 (DOUBLE MUTANT) COMPLEXED WITH CYCLOSPORIN A                         
REMARK 900 RELATED ID: 1XQ7   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYCLOPHILIN                   
REMARK 900 COMPLEXED WITH CYCLOSPORIN A                                         
REMARK 900 RELATED ID: 2ESL   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN C COMPLEXED WITH              
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 2OJU   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN J COMPLEXED WITH              
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 2POY   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF CRYPTOSPORIDIUM PARVUM IOWA II                  
REMARK 900 CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN A                           
REMARK 900 RELATED ID: 2RMA   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH              
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 2RMB   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH              
REMARK 900 MODIFIED CYCLOSPORIN A AT POSITION 5                                 
REMARK 900 RELATED ID: 2RMC   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF MURINE CYCLOPHILIN C COMPLEXED WITH             
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 2WFJ   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE PPIASE DOMAIN OF HUMAN CYCLOPHILIN          
REMARK 900 G COMPLEXED WITH CYCLOSPORIN A                                       
REMARK 900 RELATED ID: 2X2C   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN ACETYL-CYPA COMPLEXED WITH                
REMARK 900 CYCLOSPORINE A                                                       
REMARK 900 RELATED ID: 2X7K   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF PPIL1 COMPLEXED WITH CYCLOSPORINE A             
REMARK 900 RELATED ID: 2Z6W   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D IN COMPLEX WITH             
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 3BO7   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF CYCLOSPHILIN A FROM TOXOPLASMA GONDII           
REMARK 900 COMPLEXED WIT CYCLOSPORIN A                                          
REMARK 900 RELATED ID: 3CYS   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF THE HUMAN CYCLOSPORIN A COMPLEXED              
REMARK 900 WITH CYCLOSPORIN A                                                   
REMARK 900 RELATED ID: 2HAQ   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF NATIVE CYCLOPHILIN FROM LEISHMANIA              
REMARK 900 DONOVANI AT 1.97 A RESOLUTION                                        
REMARK 999                                                                      
REMARK 999 SEQUENCE                                                             
REMARK 999 THE N-TERMINAL 5 RESIDUES 'HHHHHH' IN CHAINS A AND B IS AN           
REMARK 999 ENGINEERED EXPRESSION TAG                                            
DBREF  3EOV A   22   187  UNP    Q9U9R3   Q9U9R3_LEIDO    22    187             
DBREF  3EOV B   22   187  UNP    Q9U9R3   Q9U9R3_LEIDO    22    187             
DBREF  3EOV C    1    11  NOR    NOR00033 NOR00033         1     11             
DBREF  3EOV D    1    11  NOR    NOR00033 NOR00033         1     11             
SEQADV 3EOV HIS A   16  UNP  Q9U9R3              EXPRESSION TAG                 
SEQADV 3EOV HIS A   17  UNP  Q9U9R3              EXPRESSION TAG                 
SEQADV 3EOV HIS A   18  UNP  Q9U9R3              EXPRESSION TAG                 
SEQADV 3EOV HIS A   19  UNP  Q9U9R3              EXPRESSION TAG                 
SEQADV 3EOV HIS A   20  UNP  Q9U9R3              EXPRESSION TAG                 
SEQADV 3EOV HIS A   21  UNP  Q9U9R3              EXPRESSION TAG                 
SEQADV 3EOV HIS B   16  UNP  Q9U9R3              EXPRESSION TAG                 
SEQADV 3EOV HIS B   17  UNP  Q9U9R3              EXPRESSION TAG                 
SEQADV 3EOV HIS B   18  UNP  Q9U9R3              EXPRESSION TAG                 
SEQADV 3EOV HIS B   19  UNP  Q9U9R3              EXPRESSION TAG                 
SEQADV 3EOV HIS B   20  UNP  Q9U9R3              EXPRESSION TAG                 
SEQADV 3EOV HIS B   21  UNP  Q9U9R3              EXPRESSION TAG                 
SEQRES   1 A  172  HIS HIS HIS HIS HIS HIS GLU PRO GLU VAL THR ALA LYS          
SEQRES   2 A  172  VAL TYR PHE ASP VAL MET ILE ASP SER GLU PRO LEU GLY          
SEQRES   3 A  172  ARG ILE THR ILE GLY LEU PHE GLY LYS ASP ALA PRO LEU          
SEQRES   4 A  172  THR THR GLU ASN PHE ARG GLN LEU CYS THR GLY GLU HIS          
SEQRES   5 A  172  GLY PHE GLY TYR LYS ASP SER ILE PHE HIS ARG VAL ILE          
SEQRES   6 A  172  GLN ASN PHE MET ILE GLN GLY GLY ASP PHE THR ASN PHE          
SEQRES   7 A  172  ASP GLY THR GLY GLY LYS SER ILE TYR GLY GLU LYS PHE          
SEQRES   8 A  172  ALA ASP GLU ASN LEU ASN VAL LYS HIS PHE VAL GLY ALA          
SEQRES   9 A  172  LEU SER MET ALA ASN ALA GLY PRO ASN THR ASN GLY SER          
SEQRES  10 A  172  GLN PHE PHE ILE THR THR ALA PRO THR PRO TRP LEU ASP          
SEQRES  11 A  172  GLY ARG HIS VAL VAL PHE GLY LYS VAL LEU ASP GLY MET          
SEQRES  12 A  172  ASP VAL VAL LEU ARG ILE GLU LYS THR LYS THR ASN SER          
SEQRES  13 A  172  HIS ASP ARG PRO VAL LYS PRO VAL LYS ILE VAL ALA SER          
SEQRES  14 A  172  GLY GLU LEU                                                  
SEQRES   1 B  172  HIS HIS HIS HIS HIS HIS GLU PRO GLU VAL THR ALA LYS          
SEQRES   2 B  172  VAL TYR PHE ASP VAL MET ILE ASP SER GLU PRO LEU GLY          
SEQRES   3 B  172  ARG ILE THR ILE GLY LEU PHE GLY LYS ASP ALA PRO LEU          
SEQRES   4 B  172  THR THR GLU ASN PHE ARG GLN LEU CYS THR GLY GLU HIS          
SEQRES   5 B  172  GLY PHE GLY TYR LYS ASP SER ILE PHE HIS ARG VAL ILE          
SEQRES   6 B  172  GLN ASN PHE MET ILE GLN GLY GLY ASP PHE THR ASN PHE          
SEQRES   7 B  172  ASP GLY THR GLY GLY LYS SER ILE TYR GLY GLU LYS PHE          
SEQRES   8 B  172  ALA ASP GLU ASN LEU ASN VAL LYS HIS PHE VAL GLY ALA          
SEQRES   9 B  172  LEU SER MET ALA ASN ALA GLY PRO ASN THR ASN GLY SER          
SEQRES  10 B  172  GLN PHE PHE ILE THR THR ALA PRO THR PRO TRP LEU ASP          
SEQRES  11 B  172  GLY ARG HIS VAL VAL PHE GLY LYS VAL LEU ASP GLY MET          
SEQRES  12 B  172  ASP VAL VAL LEU ARG ILE GLU LYS THR LYS THR ASN SER          
SEQRES  13 B  172  HIS ASP ARG PRO VAL LYS PRO VAL LYS ILE VAL ALA SER          
SEQRES  14 B  172  GLY GLU LEU                                                  
SEQRES   1 C   11  DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA                  
SEQRES   1 D   11  DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA                  
HET    DAL  C   1       5                                                       
HET    MLE  C   2       9                                                       
HET    MLE  C   3       9                                                       
HET    MVA  C   4       8                                                       
HET    BMT  C   5      13                                                       
HET    ABA  C   6       6                                                       
HET    SAR  C   7       5                                                       
HET    MLE  C   8       9                                                       
HET    MLE  C  10       9                                                       
HET    DAL  D   1       5                                                       
HET    MLE  D   2       9                                                       
HET    MLE  D   3       9                                                       
HET    MVA  D   4       8                                                       
HET    BMT  D   5      13                                                       
HET    ABA  D   6       6                                                       
HET    SAR  D   7       5                                                       
HET    MLE  D   8       9                                                       
HET    MLE  D  10       9                                                       
HETNAM     DAL D-ALANINE                                                        
HETNAM     MLE N-METHYLLEUCINE                                                  
HETNAM     MVA N-METHYLVALINE                                                   
HETNAM     BMT 4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE                  
HETNAM     ABA ALPHA-AMINOBUTYRIC ACID                                          
HETNAM     SAR SARCOSINE                                                        
FORMUL   3  DAL    2(C3 H7 N O2)                                                
FORMUL   3  MLE    8(C7 H15 N O2)                                               
FORMUL   3  MVA    2(C6 H13 N O2)                                               
FORMUL   3  BMT    2(C10 H19 N O3)                                              
FORMUL   3  ABA    2(C4 H9 N O2)                                                
FORMUL   3  SAR    2(C3 H7 N O2)                                                
FORMUL   5  HOH   *76(H2 O)                                                     
HELIX    1   1 ALA A   52  GLY A   65  1                                  14    
HELIX    2   2 THR A  141  ASP A  145  5                                   5    
HELIX    3   3 GLY A  157  GLU A  165  1                                   9    
HELIX    4   4 ASN A  170  ARG A  174  5                                   5    
HELIX    5   5 ALA B   52  GLY B   65  1                                  14    
HELIX    6   6 THR B  141  ASP B  145  5                                   5    
HELIX    7   7 GLY B  157  GLU B  165  1                                   9    
HELIX    8   8 ASN B  170  ARG B  174  5                                   5    
SHEET    1  AA 8 ARG A  78  ILE A  80  0                                        
SHEET    2  AA 8 MET A  84  GLY A  87 -1  O  MET A  84   N  ILE A  80           
SHEET    3  AA 8 PHE A 134  THR A 137 -1  O  PHE A 134   N  GLY A  87           
SHEET    4  AA 8 ALA A 119  MET A 122 -1  O  ALA A 119   N  THR A 137           
SHEET    5  AA 8 VAL A 150  ASP A 156 -1  N  PHE A 151   O  LEU A 120           
SHEET    6  AA 8 GLU A  38  LEU A  47 -1  O  THR A  44   N  LEU A 155           
SHEET    7  AA 8 LYS A  28  ILE A  35 -1  O  VAL A  29   N  ILE A  45           
SHEET    8  AA 8 VAL A 179  GLU A 186 -1  O  LYS A 180   N  MET A  34           
SHEET    1  BA 8 ARG B  78  ILE B  80  0                                        
SHEET    2  BA 8 MET B  84  GLY B  87 -1  O  MET B  84   N  ILE B  80           
SHEET    3  BA 8 PHE B 134  THR B 137 -1  O  PHE B 134   N  GLY B  87           
SHEET    4  BA 8 ALA B 119  MET B 122 -1  O  ALA B 119   N  THR B 137           
SHEET    5  BA 8 VAL B 150  ASP B 156 -1  N  PHE B 151   O  LEU B 120           
SHEET    6  BA 8 PRO B  39  LEU B  47 -1  O  THR B  44   N  LEU B 155           
SHEET    7  BA 8 LYS B  28  MET B  34 -1  O  VAL B  29   N  ILE B  45           
SHEET    8  BA 8 LYS B 180  GLU B 186 -1  O  LYS B 180   N  MET B  34           
LINK         N   DAL C   1                 C   ALA C  11     1555   1555  1.33  
LINK         C   DAL C   1                 N   MLE C   2     1555   1555  1.33  
LINK         C   MLE C   2                 N   MLE C   3     1555   1555  1.33  
LINK         C   MLE C   3                 N   MVA C   4     1555   1555  1.33  
LINK         C   MVA C   4                 N   BMT C   5     1555   1555  1.33  
LINK         C   BMT C   5                 N   ABA C   6     1555   1555  1.33  
LINK         C   ABA C   6                 N   SAR C   7     1555   1555  1.33  
LINK         C   SAR C   7                 N   MLE C   8     1555   1555  1.33  
LINK         C   MLE C   8                 N   VAL C   9     1555   1555  1.33  
LINK         C   VAL C   9                 N   MLE C  10     1555   1555  1.33  
LINK         C   MLE C  10                 N   ALA C  11     1555   1555  1.33  
LINK         N   DAL D   1                 C   ALA D  11     1555   1555  1.33  
LINK         C   DAL D   1                 N   MLE D   2     1555   1555  1.33  
LINK         C   MLE D   2                 N   MLE D   3     1555   1555  1.33  
LINK         C   MLE D   3                 N   MVA D   4     1555   1555  1.33  
LINK         C   MVA D   4                 N   BMT D   5     1555   1555  1.34  
LINK         C   BMT D   5                 N   ABA D   6     1555   1555  1.32  
LINK         C   ABA D   6                 N   SAR D   7     1555   1555  1.34  
LINK         C   SAR D   7                 N   MLE D   8     1555   1555  1.33  
LINK         C   MLE D   8                 N   VAL D   9     1555   1555  1.34  
LINK         C   VAL D   9                 N   MLE D  10     1555   1555  1.33  
LINK         C   MLE D  10                 N   ALA D  11     1555   1555  1.33  
SITE     1 AC1 17 ARG A  78  PHE A  83  GLN A  86  GLY A  95                    
SITE     2 AC1 17 ALA A 123  ASN A 124  GLN A 133  TRP A 143                    
SITE     3 AC1 17 HIS A 148  PRO B 127  TRP B 143  ARG B 147                    
SITE     4 AC1 17 HOH C2001  MLE D   3  BMT D   5  MLE D  10                    
SITE     5 AC1 17 ALA D  11                                                     
SITE     1 AC2 17 PRO A 127  TRP A 143  ARG A 147  ARG B  78                    
SITE     2 AC2 17 PHE B  83  GLN B  86  GLY B  95  ALA B 123                    
SITE     3 AC2 17 ASN B 124  GLN B 133  PHE B 135  TRP B 143                    
SITE     4 AC2 17 HIS B 148  MLE C   3  BMT C   5  MLE C  10                    
SITE     5 AC2 17 ALA C  11                                                     
CRYST1   69.810   83.125   73.580  90.00 103.03  90.00 C 1 2 1       8          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.014325  0.000000  0.003315        0.00000                         
SCALE2      0.000000  0.012030  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.013950        0.00000